We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$11.2B
AUM Growth
+$4.26B
(+61%)
Cap. Flow
+$3.37B
Cap. Flow
% of AUM
30.06%
Top 10 Holdings %
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294
Avg Time Held Equity + Options
1.3
quarters
Top 10 Avg Time Held Equity + Options
0.9
quarters
Top 20 Avg Time Held Equity + Options
0.9
quarters
Avg Time Held Equity only
1.2
quarters
Top 10 Avg Time Held Equity only
0.9
quarters
Top 20 Avg Time Held Equity only
0.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
+$645M |
| 2 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$539M |
| 3 |
MXIM
Maxim Integrated Products
MXIM
|
+$525M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$520M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$475M |
| 2 |
RP
RealPage, Inc.
RP
|
+$281M |
| 3 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$209M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$170M |
| 5 |
CLGX
Corelogic, Inc.
CLGX
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.69% |
| 2 | Healthcare | 19.01% |
| 3 | Financials | 14.31% |
| 4 | Real Estate | 10.94% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
526
Choice Hotels
CHH
$4.64B
| $1.08M | 0.01% |
9,125
+825
| +10% | +$95.9K |
2021 Q1
1 quarter
|
|
|
BSN
527
DELISTED
Broadstone Acquisition Corp.
BSN
| $1.08M | 0.01% |
109,595
-40,004
| -27% | -$394K |
2020 Q4
2 quarters
|
|
528
EPR Properties
EPR
$4.19B
| $1.05M | 0.01% |
+20,000
| New | +$994K |
2021 Q2
0 quarters
|
|
529
Blackstone Mortgage Trust
BXMT
$1.77B
| $1.04M | 0.01% |
+32,700
| New | +$1.05M |
2021 Q2
0 quarters
|
|
|
BTRS
530
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $1.01M | 0.01% |
80,000
| – | – |
2021 Q1
1 quarter
|
|
|
KVSC
531
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $1M | 0.01% |
101,357
+965
| +1% | +$9.68K |
2021 Q1
1 quarter
|
|
|
BRIVU
532
DELISTED
B. Riley Principal 250 Merger Corp. Units
BRIVU
| $1M | 0.01% |
+100,392
| New | +$1M |
2021 Q2
0 quarters
|
|
|
VLATU
533
DELISTED
Valor Latitude Acquisition Corp. Unit
VLATU
| $998K | 0.01% |
+100,392
| New | +$1M |
2021 Q2
0 quarters
|
|
|
GFOR.U
534
DELISTED
Graf Acquisition Corp. IV Units, each consisting of one share of common stock, and one-fifth of one redeemable warrant
GFOR.U
| $995K | 0.01% |
+100,000
| New | +$996K |
2021 Q2
0 quarters
|
|
535
MGM Resorts International
MGM
$7.36B
| $992K | 0.01% |
+23,265
| New | +$962K |
2021 Q2
0 quarters
|
|
536
Piedmont Realty Trust
PDM
$1.12B
| $992K | 0.01% |
53,700
+20,758
| +63% | +$386K |
2020 Q3
3 quarters
|
|
|
DIDI
537
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
| $990K | 0.01% |
+70,000
| New | +$990K |
2021 Q2
0 quarters
|
|
538
DELISTED
Maquia Capital Acquisition Corporation Class A Common Stock
MAQC
| $988K | 0.01% |
+100,392
| New | +$998K |
2021 Q2
0 quarters
|
|
539
Hudson Pacific Properties
HPP
$631M
| $979K | 0.01% |
5,029
+472
| +10% | +$93.3K |
2021 Q1
1 quarter
|
|
|
BGRY
540
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $975K | 0.01% |
97,821
-377,657
| -79% | -$3.77M |
2021 Q1
1 quarter
|
|
541
DELISTED
Catcha Investment Corp
CHAA
| $968K | 0.01% |
+100,000
| New | +$975K |
2021 Q2
0 quarters
|
|
|
CYXT
542
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $956K | 0.01% |
95,579
-254,210
| -73% | -$2.53M |
2020 Q4
2 quarters
|
|
543
Sabra Healthcare REIT
SBRA
$4.9B
| $915K | 0.01% |
50,300
-50,900
| -50% | -$906K |
2021 Q1
1 quarter
|
|
544
CareTrust REIT
CTRE
$8.59B
| $904K | 0.01% |
38,900
-67,500
| -63% | -$1.59M |
2020 Q2
4 quarters
|
|
545
PUT
Tesla
TSLA
$1.45T
| $902K | 0.01% |
60,000
-75,000
| -56% | -$16.3M |
2018 Q2
12 quarters
|
|
|
KSU
546
CALL
DELISTED
Kansas City Southern
KSU
| $858K | 0.01% |
+151,800
| New | +$43.8M |
2021 Q2
0 quarters
|
|
547
Redwood Trust
RWT
$371M
| $857K | 0.01% |
+71,000
| New | +$792K |
2021 Q2
0 quarters
|
|
|
RTP.WS
548
DELISTED
Reinvent Technology Partners Redeemable Warrants, each whole warrant exercisable for one Class A ord
RTP.WS
| $855K | 0.01% |
437,484
| – | – |
2021 Q1
1 quarter
|
|
549
Surrozen
SRZN
$279M
| $822K | 0.01% |
5,517
-4,476
| -45% | -$663K |
2021 Q1
1 quarter
|
|
550
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $810K | 0.01% |
3,250,000
-2,250,000
| -41% | -$196M |
2018 Q4
10 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q2 2021 Portfolio in Review
As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
UBS O'Connor deployed $3.37B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.
- UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
- UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
- UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
- UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
- UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
- UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
- UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.
Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.